Daniele Moratto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniele Moratto has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Biondi
School of Medicine and Surgery University of Milano‐Bicocca Monza MB Italy
2 shared publications - Francesco Saettini
Department of Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Italy
2 shared publications - Maria Iascone
Laboratory of Medical Genetics, Papa Giovanni XXIII Hospital Bergamo Italy
2 shared publications - Raffaele Badolato
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
2 shared publications Alessandra Beghin
Stem Cell Laboratory Section of Hematology and Blood Coagulation Clinical Chemistry Laboratory Diagnostics Department ASST Spedali Civili of Brescia Brescia Italy
1 shared publicationAlessandra Pangrazio
Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Segrate 20090, Italy
1 shared publication
Latest Publications
- 15 September 2023
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (12) , e30671
Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function
We report a novel case of SMARCD2 (SWI/SNF‐related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily D, member 2) mutation successfully treated with hematopoietic stem cell transplantation. The female patient presented delayed cord separation, chronic diarrhea, skin abscesses, skeletal dysmorphisms, and neutropenia with specific granule deficiency. Analysis of the transcriptomic profile of peripheral blood sorted mature and immature SMARCD2 neutrophils showed defective maturation process that associated with altered expression of genes related to specific, azurophilic, and gelatinase granules, such as LTF, CRISP3, PTX3, and CHI3L1. These abnormalities account for the prevalence of immature neutrophils in the peripheral blood, impaired function, and deregulated inflammatory responses.
- 15 September 2023
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (12) , e30671
Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function
We report a novel case of SMARCD2 (SWI/SNF‐related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily D, member 2) mutation successfully treated with hematopoietic stem cell transplantation. The female patient presented delayed cord separation, chronic diarrhea, skin abscesses, skeletal dysmorphisms, and neutropenia with specific granule deficiency. Analysis of the transcriptomic profile of peripheral blood sorted mature and immature SMARCD2 neutrophils showed defective maturation process that associated with altered expression of genes related to specific, azurophilic, and gelatinase granules, such as LTF, CRISP3, PTX3, and CHI3L1. These abnormalities account for the prevalence of immature neutrophils in the peripheral blood, impaired function, and deregulated inflammatory responses.
- Open Access
- 9 March 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (7) , 2129-2134
Identical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype
The Rubinstein–Taybi syndrome (RSTS) is a rare developmental disorder characterized by craniofacial dysmorphisms, broad thumbs and toes, intellectual disability, growth deficiency, and recurrent infections. Mutations in the cyclic adenosine monophosphate response element‐binding protein (CREB)‐binding protein (CREBBP) or in the E1A‐associated protein p300 (EP300) genes have been demonstrated in 55% (RSTS1) and up to 8% of the patients (RSTS2), respectively. Dysfunction of immune response has been reported in a subgroup of individuals with RSTS. Here we characterize two patients carrying the same EP300 variant and distinctive RSTS features (including congenital heart abnormalities, short stature, feeding problems, and gastroesophageal reflux). Whole exome sequencing did not support a dual molecular diagnosis hypothesis. Nonetheless, patients showed distinct clinical manifestations and immunological features. The most severe phenotype was associated with reduced T‐cell production and diversity. This latter feature was confirmed in a control group of four RSTS patients.
- 9 March 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (7) , 2129-2134
Open AccessIdentical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype
The Rubinstein–Taybi syndrome (RSTS) is a rare developmental disorder characterized by craniofacial dysmorphisms, broad thumbs and toes, intellectual disability, growth deficiency, and recurrent infections. Mutations in the cyclic adenosine monophosphate response element‐binding protein (CREB)‐binding protein (CREBBP) or in the E1A‐associated protein p300 (EP300) genes have been demonstrated in 55% (RSTS1) and up to 8% of the patients (RSTS2), respectively. Dysfunction of immune response has been reported in a subgroup of individuals with RSTS. Here we characterize two patients carrying the same EP300 variant and distinctive RSTS features (including congenital heart abnormalities, short stature, feeding problems, and gastroesophageal reflux). Whole exome sequencing did not support a dual molecular diagnosis hypothesis. Nonetheless, patients showed distinct clinical manifestations and immunological features. The most severe phenotype was associated with reduced T‐cell production and diversity. This latter feature was confirmed in a control group of four RSTS patients.
- 4 August 2018
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 29 (7) , 776-781
A novel EP300 mutation associated with Rubinstein‐Taybi syndrome type 2 presenting as combined immunodeficiency
- 4 August 2018
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 29 (7) , 776-781
A novel EP300 mutation associated with Rubinstein‐Taybi syndrome type 2 presenting as combined immunodeficiency
- 1 July 2008
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 83 (1) , 64-76
Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations
- 1 July 2008
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 83 (1) , 64-76
Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations